BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-732@pharmaconomics
DTSTAMP:20260707T021625Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:CYTK Approval — aficamten (estimated date)
DESCRIPTION:A final FDA approval decision on aficamten for obstructive hypertrophic cardiomyopathy is expected ~ Dec 31\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1061983/000119312526067012/cytk-ex99_1.htm\n\nTrack it: https://pharmaconomics.com/e/732
URL:https://pharmaconomics.com/e/732
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:CYTK catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR